|

China Registry for Genetic / Metabolic Liver Diseases

RECRUITINGSponsored by Beijing Friendship Hospital
Actively Recruiting
SponsorBeijing Friendship Hospital
Started2015-06-13
Est. completion2022-04-28
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03131427

Summary

CR-GMLD registry started on June 13, 2015 to collect cases of genetic/metabolic liver diseases from tertiary or secondary hospitals in mainland China. Demographics, diagnosis, laboratory test results, family history and prescriptions were recorded. Patients' whole blood and serum were collected for genetic testing and future researches. These patients will be followed-up every six to twelve months.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

Patients who were diagnosed or possibly diagnosed with Wilson's disease, hereditary hemochromatosis, hereditary hyperbilirubinemias, inherited cholestatic liver disease or other genetic/metabolic liver diseases.

Exclusion Criteria:

Patients who are unable or unwilling to provide informed consent.

Conditions2

Genetic/Metabolic Liver DiseasesLiver Disease

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.